e-learning
resources
Vienna 2012
Monday, 03.09.2012
Tuberculosis: clinical findings III
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Granulamatous mastitis treated as tuberculosis: Preliminary results of surveillance programme
C. Ozdilekcan, F. Agca, S. Turanli, U. Ok, I. Pak (Ankara, Turkey)
Source:
Annual Congress 2012 - Tuberculosis: clinical findings III
Session:
Tuberculosis: clinical findings III
Session type:
Thematic Poster Session
Number:
2619
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Ozdilekcan, F. Agca, S. Turanli, U. Ok, I. Pak (Ankara, Turkey). Granulamatous mastitis treated as tuberculosis: Preliminary results of surveillance programme. Eur Respir J 2012; 40: Suppl. 56, 2619
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses
Source: Eur Respir J 2001; 18: Suppl. 33, 473s
Year: 2001
Evaluation of non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis: Interim analysis of a TBNET study
Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2012
Peculiarities in implementation of national tuberculosis program in patients with smear negative pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 190s
Year: 2004
Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience
Source: Eur Respir J , 49 (3) 1602049; DOI: 10.1183/13993003.02049-2016
Year: 2017
Intrahospital mortality of tuberculosis – our experience of national tuberculosis program implementation
Source: Eur Respir J 2006; 28: Suppl. 50, 129s
Year: 2006
Surgical treatment for MDR TB patients – preliminary results from a Romanian MDR TB centre
Source: Eur Respir J 2006; 28: Suppl. 50, 276s
Year: 2006
Results of multicentral external quality assessment for
M. tuberculosis
drug susceptibility testing in Russia
Source: Eur Respir J 2005; 26: Suppl. 49, 646s
Year: 2005
Long-term results of multidrug-resistant tuberculosis treatment.
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Evaluation of follow up and treatment results of new tuberculosis cases
Source: Eur Respir J 2003; 22: Suppl. 45, 522s
Year: 2003
Household TB case finding results and clinical improvement of children with endobronchial tuberculosis
Source: Annual Congress 2009 - Tuberculosis at different age groups
Year: 2009
New guidelines for screening for tuberculosis and latent tuberculosis infection pre-immunosuppressive therapy in the Netherlands: a targeted and stratified approach
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Bedaquiline (BQ)-containing regimen at the programmatic level for MDR-TB: preliminary results
Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Year: 2017
Effectiveness of mandatory treatment for tuberculosis - An observational registry study
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013
Routine liver function test monitoring of patients treated for active M.TB infection does not influence management: A real-world retrospective study
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018
Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Acceptability of screening for tuberculosis in three settings: a qualitative study
Source: Eur Respir J 2004; 24: Suppl. 48, 192s
Year: 2004
Results of retrospective-prospective comparison study of different immunologic tests in diagnosis of tuberculosis infection
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Results of the implementation of the WHO-recommended TB control strategy in Russia
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
Source: Eur Respir J 2015; 46: 1563-1576
Year: 2015
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden
Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept